Codexis to Participate in Upcoming Healthcare Conferences
Codexis (NASDAQ: CDXS) has announced its participation in four major healthcare conferences in November 2024. The company will engage in fireside chats at the Stifel Healthcare Conference (New York, November 18), the Jefferies London Healthcare Conference (London, November 19), and the Stephens Annual Investment Conference (Nashville, November 21). Additionally, management will host one-on-one investor meetings at the Craig-Hallum Alpha Select Conference in New York on November 19. Live webcasts of the fireside chats will be available on Codexis's investor relations website, with replays accessible for 90 days post-presentation.
Codexis (NASDAQ: CDXS) ha annunciato la sua partecipazione a quattro importanti conferenze nel settore della salute nel novembre 2024. L'azienda parteciperà a conversazioni informali al Stifel Healthcare Conference (New York, 18 novembre), al Jefferies London Healthcare Conference (Londra, 19 novembre) e al Stephens Annual Investment Conference (Nashville, 21 novembre). Inoltre, il management ospiterà incontri individuali con investitori al Craig-Hallum Alpha Select Conference di New York il 19 novembre. Le dirette streaming delle conversazioni informali saranno disponibili sul sito web delle relazioni con gli investitori di Codexis, con riproduzioni accessibili per 90 giorni dopo la presentazione.
Codexis (NASDAQ: CDXS) ha anunciado su participación en cuatro importantes conferencias de salud en noviembre de 2024. La empresa participará en charlas informales en la Stifel Healthcare Conference (Nueva York, 18 de noviembre), en la Jefferies London Healthcare Conference (Londres, 19 de noviembre) y en la Stephens Annual Investment Conference (Nashville, 21 de noviembre). Además, la dirección realizará reuniones individuales con inversores en la Craig-Hallum Alpha Select Conference en Nueva York el 19 de noviembre. Las transmisiones en vivo de las charlas informales estarán disponibles en el sitio web de relaciones con inversores de Codexis, con repeticiones accesibles durante 90 días después de la presentación.
Codexis (NASDAQ: CDXS)는 2024년 11월에 열리는 네 개의 주요 건강 관리 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 Stifel Healthcare Conference (뉴욕, 11월 18일), Jefferies London Healthcare Conference (런던, 11월 19일) 및 Stephens Annual Investment Conference (내슈빌, 11월 21일)에서 편안한 대화에 참여할 것입니다. 또한 경영진은 11월 19일 뉴욕의 Craig-Hallum Alpha Select Conference에서 투자자와의 개별 회의를 주최할 예정입니다. 편안한 대화의 라이브 웹 방송은 Codexis의 투자자 관계 웹사이트에서 제공되며, 발표 후 90일 동안 다시 시청할 수 있습니다.
Codexis (NASDAQ: CDXS) a annoncé sa participation à quatre grandes conférences sur la santé en novembre 2024. L'entreprise participera à des discussions informelles lors de la Stifel Healthcare Conference (New York, 18 novembre), de la Jefferies London Healthcare Conference (Londres, 19 novembre) et de la Stephens Annual Investment Conference (Nashville, 21 novembre). De plus, la direction organisera des réunions individuelles avec des investisseurs lors de la Craig-Hallum Alpha Select Conference à New York le 19 novembre. Les webinaires en direct des discussions informelles seront disponibles sur le site web des relations investisseurs de Codexis, avec des rediffusions accessibles pendant 90 jours après la présentation.
Codexis (NASDAQ: CDXS) hat seine Teilnahme an vier wichtigen Gesundheitskonferenzen im November 2024 bekannt gegeben. Das Unternehmen wird an informellen Gesprächen auf der Stifel Healthcare Conference (New York, 18. November), der Jefferies London Healthcare Conference (London, 19. November) und der Stephens Annual Investment Conference (Nashville, 21. November) teilnehmen. Zudem wird das Management am 19. November Einzelgespräche mit Anlegern auf der Craig-Hallum Alpha Select Conference in New York führen. Live-Übertragungen der informellen Gespräche werden auf der Investor-Relations-Website von Codexis verfügbar sein, mit Wiederholungen, die 90 Tage nach der Präsentation zugänglich sind.
- None.
- None.
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that management will participate in four upcoming investor conferences.
The Stifel 2024 Healthcare Conference (New York, NY)
- Monday, November 18, 2024, at 2:25 pm ET, management will participate in a fireside chat
The Jefferies London Healthcare Conference (London, UK)
- Tuesday, November 19, 2024, at 9:30 am GMT, management will participate in a fireside chat
The 15th Annual Craig-Hallum Alpha Select Conference (New York, NY)
- Tuesday, November 19, 2024, management will host 1x1 investor meetings
The Stephens Annual Investment Conference (Nashville, TN)
- Thursday, November 21, 2024, at 12:00 pm CT, management will participate in a fireside chat
Live webcasts of each fireside chat will be available on the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay of each fireside chat will be archived for 90 days following the presentation date.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com
FAQ
What healthcare conferences will Codexis (CDXS) attend in November 2024?
Where can investors watch Codexis (CDXS) conference presentations in November 2024?